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Surgical Management of a Recurrent Leiomyosarcoma of the Inferior Vena Cava Requiring Aortobifemoral Bypass
Objectives: Leiomyosarcoma involving the inferior vena cava (IVC) is a rare neoplasm with a high rate of recurrence despite aggressive surgical management. A recent pooled analysis of IVC leiomyosarcoma literature found 371 cases detailing primary tumors, but only nine reoperative cases were described. We present a unique case of an aggressive IVC leiomyosarcoma with local recurrence, which was managed with extensive surgical reconstruction including nephrectomy and aortobifemoral bypass.
Methods: A 48-year-old woman presented with a several years' history of back and abdominal pain. Computed tomography (CT) of the abdomen revealed a mass involving her IVC. Subsequent biopsy demonstrated a grade 3 leiomyosarcoma. There was no lymph node involvement. She underwent resection of the tumor and involved segment of IVC, which was reconstructed with an interposition graft. Although intraoperative sections were negative, permanent sections revealed the closest surgical margin was <1 mm. The patient was not compliant with follow-up and did not undergo adjuvant radiation or chemotherapy at that time. Three months later an abdominal CT scan demonstrated renal scarring, possible renal vein thrombosis, and enhancement within the IVC felt to represent thrombosis. Shortly thereafter, she began experiencing progressive, severe abdominal pain and weight loss. A subsequent CT scan 6 months later demonstrated an extensive locally recurrent retroperitoneal mass at the level of the renal vein that involved the right kidney, engulfed the aorta, and obstructed the IVC reconstruction (Fig) .
Results: The patient underwent 6 weeks of neoadjuvant radiation therapy and subsequent surgical resection. Given the extensive nature of the tumor, the resection required IVC ligation, total right nephrectomy, and aortic resection with reconstruction utilizing an aortobifemoral graft. The patient tolerated the procedure well and was subsequently discharged home.
Conclusions: Primary leiomyosarcoma of the IVC has reported recurrence rates of up to 90%. Negative margins of resection have been shown to correlate with improved survival, but as few as 6% of reported cases involve an aortic reconstruction. We report the resection of a primary IVC leiomyosarcoma that, despite negative margins of resection, demonstrated subsequent extensive local recurrence requiring aortic reconstruction. We postulate that aortic resection with reconstruction should be considered in cases with suboptimal oncologic margins, given the risk of recurrence. Objectives: Therapeutic anticoagulation is associated with higher postoperative bleeding and transfusions. Postoperative subtherapeutic low-dose heparin infusion (LDHI) is commonly administered in select patients undergoing open limb arterial revascularization to maintain graft patency, while decreasing the risk of perioperative complications. However, the safety and efficacy of this management strategy is unknown.
Methods: From January 2013 to December 2015, all patients undergoing aortoiliac, and upper or lower extremity arterial revascularization who were randomly selected from our institution for inclusion in the National Surgical Quality Improvement Program were retrospectively reviewed. Patients were grouped by receipt of LDHI within the first 24 hours after surgery. Preoperative demographics, comorbidities, intraoperative measures, National Surgical Quality Improvement Program-defined postoperative complications, patency and amputation rates were analyzed for each group. Student t-test, c 2 analysis, and logistic regression were used for univariate and multivariate comparisons. Kaplan-Meier methods and Cox proportional hazards regression were used to assess univariate and multivariate survival, primary patency, and amputationfree survival.
Results: Of 379 patients, 56 (14.8%) received LDHI. Age, gender, body mass index, race, comorbidities, American Society of Anesthesiologists class, and procedure type were similar between LDHI and no-LDHI groups. LDHI patients were less likely to have an elective admission (26.8% vs 56%; P < .001) or an admission from home (69.6% vs 81.7%; P ¼ .04). They were also more likely to have preoperative bleeding (44.6% vs 22%; P < .01) and need for emergent operation (23.2% vs 11.8%; P ¼ .04). Postoperatively, LDHI patients were more likely to be bridged to anticoagulation (16.4% vs 78.6%; P < .001), and trended towards increased postoperative bleeding (48.2% vs 33.7%; P ¼ .053). LDHI patients also demonstrated no increase in 30-day mortality (1.79% vs 1.24%; P ¼ .55) or return to the operating room (19.7% vs 12.4%; P ¼ .21). At 2 years, LDHI patients had decreased primary patency (61.6% vs 76.9%; P ¼ .01), decreased freedom from amputation (72.9% vs 85.8%; P ¼ .01), but unchanged survival (P ¼ .33; Fig) . Multivariate analysis demonstrated that LDHI did not have a significant association with immediate 
